Erik Mellgren
Erik Mellgren is a Swedish journalist who worked for Xconomy Boston in 2008 as part of the Stanford Innovation Journalism Fellowship program. He is a 26-year veteran of Ny Teknik, a leading technology and innovation magazine in Sweden.
Recent posts
-
The mobile search and advertising specialist JumpTap, based in Cambridge, MA, says it will open new offices in Madrid, Spain, and Stockholm, Sweden. The expansion is in response to the... Read more »
-
Specialty pharmaceutical company Biovitrum of Stockholm, Sweden said today that it has begun human clinical tests of its new anti-hemophilia drug, a recombinant form of a blood-clotting protein called Factor IX that it... Read more »
-
In case you haven’t heard enough about business plans lately (think MIT $100K Entrepreneurship Competition, the Ignite Clean Energy Competition, and the $200K MIT Clean Energy Entrepreneurship Prize), here’s... Read more »
-
If you think the director got it wrong, well go ahead and change the movie. That is the basic idea behind a new service, offered by cable television channel Lifetime, using... Read more »
-
British drug company Antisoma reported today that it has picked up Cambridge, MA-based Xanthus Pharmaceuticals for about $52 million in shares. Xanthus focuses on therapies for cancer and autoimmune diseases and... Read more »
-
If you ride a bike to work this week, chances are that somebody will give you, if not a free lunch, then at least a free breakfast. The meals are one of the activities... Read more »
-
It’s been a big week for FloDesign Wind Turbine. On Monday the company placed first in the MIT Enterprise Forum’s Ignite Clean Energy Competition, winning $100,000 in cash and services. On... Read more »
-
Xconomist Noubar Afeyan, co-founder and CEO of Flagship Ventures in Cambridge, MA, was one of those awarded the Ellis Island Medal of Honor by the National Ethnic Coalition (NECO) over the... Read more »
-
Last Thursday, I met Chad Lovell, a first-year student at MIT, standing in a small lobby on the third floor of a State Street office building in downtown Boston. It was the day of the... Read more »
-
Yesterday we told you that Boston Scientific (NYSE: BSX) had got its new family of advanced pacemakers approved for sale in Europe, but that these were not available in... Read more »
-
Boston Scientific of Natick, MA, will start selling a new line of advanced pacemakers in the European Union. The company announced today that the devices have received the CE Mark of approval... Read more »
-
If you still think that e-mail and Internet are things you get on your computer, then you’re probably my age. Or maybe half my age.
I got a taste of the new generation... Read more »
-
Two Boston-area biotech companies have reached clinical milestones that will earn them a total of $10.5 million from their industry partners.
Epix Pharmaceuticals of Lexington, MA, announced today that it has begun phase... Read more »
-
I went to the Museum of Science yesterday, to see “Cambridge’s premier companies show-off their latest research and products, revealing what makes them world leaders in science!” At least, that was... Read more »
-
Concert Pharmaceuticals may have found a way to help established drug substances pack a better punch. By substituting a few normal hydrogen atoms with the heavier form, deuterium, the company believes it is possible... Read more »
-
Constellation Pharmaceuticals, a new drug-discovery company based in Cambridge, MA, today announced that it has raised $32 million in Series A financing.
One of the lead investors in the deal is Boston’s Third... Read more »
-
Ambient of Newton, MA, develops technology that makes it possible to use the existing electric power grid as a lightning-fast broadband network. The company today announced that it has secured $3 million... Read more »
-
Retail Convergence, an e-commerce corporation based in Boston, today announced it has raised $25 Million from a number of investors, including New England Development, Breakaway Ventures, Mugar Enterprises, and General Catalyst. The... Read more »
-
A gang of outsiders just arrived in town. Yesterday, at a conference in San Diego, ZS Genetics announced that it is the seventh team to be accepted into the race for the... Read more »
-
Back in November, David Stipp wrote about how Resolvyx Pharmaceuticals of Bedford, MA, is aiming to turn the science of fish oil into treatments for a host of inflammatory diseases, from... Read more »
